STELLA SHI

Stella (Yibin) Shi, is a Principal with Lilly Asia Ventures (LAV). Prior to joining LAV, Stella was a new product planning manager at Roche Asia Pacific, where she was in charge of oncology pipeline strategy. Previously, Stella worked at ZS Associates Shanghai office, where she worked primarily with biopharma and medtech clients on strategy projects spanning sales, marketing, operation and commercialization. Stella was born in Shanghai, China and received her BS of biology degree from Fudan University with top scholarship (top 10%).